Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 108
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.01-020 - Phase 2 Platform Trial of Anti-TIGIT GSK’859A/EOS-448 + Anti-PD-1 Dostarlimab in Non-small Cell Lung Cancer (NSCLC)
Author(s): David Spigel- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-131 - Alectinib after Crizotinib Failure in Patients with Advanced ALK‑Positive NSCLC: Results from the Spanish Early Access Program
Author(s): Reyes Bernabé-Caro- Abstract
Loading... -
+
EP08.02-070 - High Incidence of Peridiagnosis Thromboembolic Events In Patients with BRAF Mutant Lung Cancer
Author(s): Inmaculada Aparicio Salcedo- Abstract
Loading...
-
+
P1.11 - Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
- Type: Regular Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
- Presentations: 2
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.11-01 - Cobolimab With Dostarlimab and Docetaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
Author(s): Hye Ryun Kim- Abstract
Loading...
-
+
OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- Presentations: 10
- Moderators:Lubos Petruzelka
- Coordinates: 8/08/2022, 11:00 - 12:00, Hall C7
-
+
OA07.01 - Session Introduction
11:00 - 11:01 | Author(s): Lubos Petruzelka
- Abstract
Loading... -
+
OA07.02 - Session Introduction
11:01 - 11:02 | Author(s): Pilar Garrido
- Abstract
Loading... -
+
OA07.03 - Association Between Genetic Variation in the ATP-binding Cassette Transporter ABCC10 and nab-PTX Treatment in Japanese Cohort
11:02 - 11:12 | Author(s): Minoru Horiuchi
- Abstract
Loading... -
+
OA07.04 - Overall Survival in Patients With Advanced NSCLC Receiving Taxane-Containing Regimen After Exposure to Immunotherapy and Platinum-Doublet
11:12 - 11:22 | Author(s): Stephen V. Liu
- Abstract
Loading... -
+
OA07.05 - Gemcitabine Plus Platinum Chemotherapy Re-challenge in Metastatic Pulmonary Lymphoepithelioma-like Carcinoma
11:22 - 11:32 | Author(s): Gavin Tin Chun Cheung
- Abstract
Loading... -
+
Session Moderator
11:22 - 11:32 | Author(s): Lubos Petruzelka
- Abstract
Loading... -
+
Session Moderator
11:22 - 11:32 | Author(s): Pilar Garrido
- Abstract
Loading... -
+
OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)
11:32 - 11:42 | Author(s): Edouard Auclin
- Abstract
Loading... -
+
OA07.07 - Discussant
11:42 - 11:52 | Author(s): Navneet Singh
- Abstract
Loading... -
+
OA07.08 - Live Q&A
11:52 - 12:00
- Abstract
Loading...
-
+
P2.07 - Pathology - Tumour Genomics
- Type: Regular Poster
- Track: Pathology - Tumour Genomics
- Presentations: 2
- Coordinates: 8/08/2022, 17:15 - 19:15, Exhibit Hall - Hall B
-
+
P2.07-02 - RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC
Author(s): Susana Hernandez- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 10
- Moderators:Pilar Garrido
- Coordinates: 8/09/2022, 14:30 - 15:30, Hall C7
-
+
Session Moderator
14:32 - 00:00 | Author(s): Pilar Garrido
- Abstract
Loading... -
+
Session Moderator
14:32 - 00:00 | Author(s): António Araújo
- Abstract
Loading... -
+
OA15.01 - Session Introduction
14:30 - 14:31 | Author(s): Pilar Garrido
- Abstract
Loading... -
+
OA15.02 - Session Introduction
14:31 - 14:32 | Author(s): António Araújo
- Abstract
Loading... -
+
OA15.03 - Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100
14:32 - 14:42 | Author(s): Martin Reck
- Abstract
Loading... -
+
OA15.04 - Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC
14:42 - 14:52 | Author(s): Solange Peters
- Abstract
Loading... -
+
OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy
14:52 - 15:02 | Author(s): Benjamin Besse
- Abstract
Loading... -
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Author(s): Delvys Rodriguez-Abreu
- Abstract
Loading... -
+
OA15.07 - Discussant
15:12 - 15:22 | Author(s): Puey Ling Chia
- Abstract
Loading... -
+
OA15.08 - Live Q&A
15:22 - 15:30
- Abstract
Loading...
